Log In
BCIQ
Print this Print this
 

Sufentanil sublingual tablet (ARX-04) (formerly Single-Dose Sufentanil NanoTab)

  Manage Alerts
Collapse Summary General Information
Company AcelRx Pharmaceuticals Inc.
DescriptionSublingual formulation of sufentanil, a synthetic mu opioid receptor (MOR; OPRM1) agonist, delivered via a disposable, prefilled, single-dose applicator
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationPain
Indication DetailsTreat moderate to severe acute pain; Treat moderate to severe acute pain associated with trauma or injury; Treat moderate to severe acute postoperative pain; Treat moderate to severe pain following ambulatory abdominal surgery
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today